Search
for
Sort by
Research 241–270 of 1000+
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- DP10 Scalp disease in dermatomyositis
- Alopecia areata
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- The use of biodegradable microneedle patches to increase penetration of topical steroid for prurigo nodularis.
- Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- STRIAA (Severity TRichoscopy Index Alopecia Areata): Validation of a Novel Trichoscopic Tool for Evaluation of Alopecia Areata
- Skin
- Inflammasome Proteins as Biomarkers of Injury and Disease
- Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis
- Trimodal mini-invasive therapy for stable-phase Peyronie's disease: a two-center real-life prospective pilot study
- Graft-versus-host disease
- Association Between Androgenetic Alopecia Severity and Sexual Dysfunction in Male and Female Patients Attending a Dermatology Clinic: An Exploratory Cross-Sectional Study
- Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Alopesia universalis pada anak yang berespon baik dengan terapi kombinasi: sebuah laporan kasus
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Patient and Clinician‐Reported Outcomes and Adherence to Calcipotriene/Betamethasone Dipropionate PAD‐Cream in Treatment of Scalp Psoriasis in Adults: An Interim Analysis of the PRO‐SCALP Study
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy